---
document_datetime: 2025-10-02 15:52:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vivlipeg-epar-all-authorised-presentations_en.pdf
document_name: vivlipeg-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7894637
conversion_datetime: 2025-12-20 17:35:29.977706
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                          | Content (concentration)   | Pack size            |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------------------------|---------------------------|----------------------|
| EU/1/25/1967/001 | Vivlipeg          | 6 mg       | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)                   | 0.6 ml (10 mg/ml)         | 1 pre-filled syringe |
| EU/1/25/1967/002 | Vivlipeg          | 6 mg       | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) with neddle guard | 0.6 ml (10 mg/ml)         | 1 pre-filled syringe |